Tag: CSL

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

KENNESAW, Ga., Aug. 1, 2025 /CNW/ -- Automated Logic – Canada, Ltd. (ALC), a leading provider of innovative building-management solutions and a part of Carrier...

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

KENNESAW, Ga., Aug. 1, 2025 /PRNewswire/ -- Automated Logic – Canada, Ltd. (ALC), a leading provider of innovative building-management solutions and a part of Carrier...

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m

MELBOURNE, Australia, July 24, 2025 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million.

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy^® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions

HD Hyundai to Transplant ‘Korean Shipbuilding DNA’ into India

Signed comprehensive MOU for cooperation in shipbuilding with Cochin Shipyard Limited, India, on July 4To provide ship design, equipment support, and technical collaboration —...

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....

U.S. Food and Drug Administration Approves CSL’s ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All...

ANDEMBRY inhibits the top of the HAE cascade by targeting factor XIIa and provides sustained protection from attacksOnce-monthly dosing reduced HAE attacks by a...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsCSL

Change of base rate margin for some exchange traded products

Viridien: Combined General Meeting and Board of Directors Meeting of June 3, 2026 – Henning Berg appointed as Chief Executive Officer and Director of...

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Tag: CSL

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

HD Hyundai to Transplant ‘Korean Shipbuilding DNA’ into India

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

U.S. Food and Drug Administration Approves CSL’s ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us